Aims: Proteus species are implicated as serious causes of various human infections. Imipenem has been used to treat infections caused by these organisms. However, Proteus spp. are known to have reduced susceptibility and have elevated minimum inhibitory concentration (MIC) towards imipenem. The aim of this study was to determine the prevalence of Proteus species with reduced susceptibility to imipenem and the antibiotic susceptibility pattern for each Proteus species. Methodology and results: A total of 204 Proteus isolates were collected from routine samples. All isolates were identified by using VITEK® 2 GN ID card. Antibiotic susceptibility tests were done by using disc diffusion method and imipenem E-test. While 5.9% of the Proteus isolates showed reduced susceptibility towards imipenem by disc diffusion, only 1% (2 out of 204 isolates) has reduced susceptibility by E-test. Conclusion, significance and impact of study: The prevalence of Proteus species with reduced susceptibility to imipenem is still low. The imipenem zone diameter does not truly reflect the MIC value and thus, in any isolates which are tested to have reduced susceptibility or resistant to imipenem should always be followed by imipenem MIC method.
INTRODUCTION
The genus Proteus is grouped together with Providentia and Morganella genera under the Proteeae tribe. They are related members of the Enterobacteriaceae families of Gram-negative bacilli that are motile, non-lactose fermenter and produce phenylalanine deaminase (Donnenberg, 2011) . The genus Proteus currently consists of five named species (P. mirabilis, P. penneri, P. vulgaris, P. myxofaciens, and P. hauseri) and three unnamed genomospecies (Proteus genomospecies 4, 5, and 6) (O'Hara et al., 2000) . Nevertheless, P. mirabilis and P. vulgaris account for the vast majority of clinical isolates in this genus.
Proteus species contribute to significant implication in the hospital setting. This pathogen is known to cause bloodstream infection, opportunistic infection, wound infection and one of the main causes of urinary tract infections (UTIs) among hospitalised patients with indwelling urinary catheters and urinary tract calculi.
Imipenem was reported to be the most effective antibiotic against Proteus species (Bahashwan and El Shafey, 2013) . Based on the Clinical and Laboratory Standards Institute (CLSI) guideline, it is known that Proteus species tends to have higher imipenem MIC (e.g. MICs in the intermediate or resistant range) compared to other enterobacteriaceae. A study in Europe had shown that, 7% of P. mirabilis isolates has reduced susceptibility towards imipenem compared to less than 1% for meropenem (Mutnick et al., 2002) . Another study had found isolates (all 16 isolates) which were fully or intermediately susceptible to imipenem (MICs of 2 to 8 mg/L) and meropenem (MICs of 0.25 to 2 mg/L) by broth microdilution (Miriagou et al., 2010) . Neuwirth et al. in his study in 1995, revealed findings suggesting that imipenem resistance in P. mirabilis might result from altered penicillin-binding proteins (PBPs) even though the strain is susceptible to other beta-lactams.
To our knowledge, there is no published data from Malaysia specifically addressing the prevalence of Proteus species with reduced susceptibility towards imipenem.
Thus, the aim of our study was mainly to determine the prevalence of Proteus species with reduced susceptibility to imipenem. Furthermore, we would like to determine the antibiotic susceptibility pattern for each Proteus species and to compare the imipenem susceptibility using disc diffusion size and E-test method among the Proteus species isolates.
MATERIALS AND METHODS

Specimen collection
A total of 204 Proteus spp. were included in the study. Non-repeated strains of Proteus species isolated from various clinical specimens in the Microbiology Laboratory, Hospital Kuala Lumpur from June 2015 till June 2016 were evaluated. The specimens included were blood, tissue, bone, urine, pus, vaginal swabs, respiratory samples, cerebrospinal fluid and sterile body fluids. The Proteus spp. isolated were subcultured on nutrient agar slants and froze at ─20 °C until further testing. The type of infections, specimens, Proteus species isolated and the antibiotic susceptibility pattern were recorded.
Cultivation and identification
All specimens were aseptically inoculated on blood agar and Mac Conkey agar. Cystine-Lactose-ElectrolyteDeficient (CLED) agar was added for urine specimens. The characteristic swarming colonies on blood agar and oxidase-negative non-lactose fermenting organism on Mac Conkey agar were identified. Presumptive Proteus colonies were identified through extended biochemical tests; triple sugar iron, indole, methyl red, citrate, motility, ornithine, phenylalanine deaminase, oxidativefermentative test, urea test and malonate. VITEK® 2 GN ID card (bioMérieux, Marcy-l'Etoile, France) was used for further confirmation of identification.
Antimicrobial susceptibility test
Mueller-Hinton agar was prepared from a commercially available dehydrated base according to the manufacturer's instructions. The agar was inoculated with Proteus species using the direct colony suspension method. The inoculum was prepared by making a direct colony suspension from an 18 to 24-hour culture. The suspension was adjusted to match the 0.5 McFarland turbidity standards, using saline and a vortex mixer.
Disc diffusion method
The Kirby-Bauer method was used as recommended by the CLSI guideline. The predetermined battery of antimicrobial discs were applied and lightly pressed onto the surface of the inoculated agar plate. The plates were then inverted and incubated at 35 °C for 16 to 18 h. The antibiotics tested include; ampicillin (10 µg), cefotaxime (30 μg), cefepime (30 μg), ceftazidime (30 μg), cefoxitin (30 μg), amoxicillin-clavulanate (20/10 µg), trimethoprimsulfamethoxazole (1.25/23.75 µg), ertapenem (10 µg), meropenem (10 µg), imipenem (10 µg), cefoperazone (75 µg), cefuroxime (30 µg), gentamicin (10 µg), amikacin (30 μg), ampicillin-sulbactam (10/10 µg), piperacillintazobactam (100/10 µg), ciprofloxacin (5 µg), chloramphenicol (30 μg) (for non-urine specimens), nitrofurantoin (300 µg) (for urine specimens) and polymyxin B (300 U). Interpretative criteria of antibiotic susceptibility were based on the 2015 CLSI breakpoints. 
E-test method
E-test is a quantitative method for antimicrobial susceptibility testing which applies both the dilution of antibiotic and diffusion of antibiotic into the medium. In the present study, all Proteus isolates were tested with Imipenem E-test. Result interpretation was based on 2015 CLSI breakpoints (Sensitive, ≤1 mcg/mL; Intermediate, 2 mcg/mL; Resistant, ≥4 mcg/mL).
RESULTS
Proteus species isolated
A total of 204 Proteus species were included in this study. Proteus mirabilis is the most common Proteus species isolated (95.1%) followed by P. penneri (3.4 %), P. hauseri (1.0%) and P. vulgaris (0.5%) ( Table 1) . Most of the Proteus sp. was isolated from urine specimen which accounted for 31.4% (n=64) followed by pus (25.5%), tissue (21.6%), blood (7.8%), bone (7.4%), respiratory (4.4%) and peritoneal fluid (1.0%). Proteus sp. were also isolated from blister aspirate and cerebrospinal fluid (0.5% each) ( Table 2 ). The greatest number of Proteus sp. were isolated from patients with urinary tract infection (UTI) (31.4%), followed by skin and soft tissue infection (SSTI) (29.9%), diabetic foot infection (21.1%), bloodstream infection (7.8%), and respiratory infection (4.4%). Proteus sp. were also isolated from cases of septic arthritis, osteomyelitis and ear infection which accounted 2.0%, 1.5% and 1.0% respectively. Other infections that isolated Proteus sp. are cases of meningitis and peritonitis (1.0% each) (Table 3) .
Antibiotic susceptibility pattern of Proteus species
The antibiotic susceptibility testing was carried out on all Proteus sp. isolates (P. mirabilis, P. penneri, P. vulgaris, and P. hauseri). Chloramphenicol discs were added to non-urine specimens (n=140) while nitrofurantoin discs for urine samples (n=64). Polymyxin B was used as one of the identification of Proteus spp. as they are innately resistant to this antibiotic. All Proteus sp. isolated were susceptible to ertapenem and meropenem but 12 (5.9%) of them show reduced susceptibility towards imipenem. More than 90% of the Proteus sp. were susceptible to ceftazidime, cefoxitin, amikacin and piperacillintazobactam representing 92.6%, 94.6%, 97.1% and 99.0%; respectively. More than 50% of the isolates were resistant to ampicillin (58.8%) and trimethoprimsulfamethoxazole (55.9%) (Figure 1 ). Proteus mirabilis isolates were largely susceptible to cephalosporin group, beta lactam-beta lactamase inhibitor, ciprofloxacin and aminoglycosides antibiotics. However, isolates from urine specimens were resistant to nitrofurantoin. Other antibiotics demonstrated variable susceptibility pattern. All P. mirabilis isolates were susceptible to ertapenem and meropenem. However, one P. mirabilis isolate was resistant to imipenem, 8 were intermediate while the remaining 186 (95.9%) were susceptible to imipenem (Figure 2 ). All P. penneri isolates (n=7) were resistant to ampicillin and cefuroxime. One P. penneri isolate was resistant to imipenem but susceptible to meropenem and ertapenem. Six isolates had reduced susceptibility to cefoperazone (Table 4 ). All P. hauseri (n=2) isolates were susceptible to all antibiotics tested. Proteus vulgaris (n=1) isolate was resistant only to ampicillin and cefuroxime. Table 5 summarizes the overall susceptibility of Proteus sp. isolates (n=204) by imipenem disc and imipenem E-test. One hundred ninety two (94.1%) isolates were imipenem sensitive by disc and E-test. Intermediate susceptibility to imipenem was detected by disc in 8 (3.9%) isolates which became sensitive when tested by E-test. Four isolates (2.0%) were resistant by imipenem disc in which 2 isolates became susceptible, 1 became intermediately sensitive and another isolate was resistant when tested with imipenem E-test. A total of 204 isolates were tested with imipenem E-test (Table 6) . Out of this, 202 (99%) isolates were susceptible. Only 2 P. mirabilis isolates had reduced susceptibility towards imipenem. One isolate had intermediate result with MIC: 2 mcg/mL and another 1 isolate was resistant with MIC: 32 mcg/mL to imipenem E-test. ISSN 
DISCUSSION
Proteus species are isolated from various anatomical sites and have been implicated in several human infections. We had identified 4 Proteus species (P. mirabilis, P. penneri, P. hauseri and P. vulgaris) to be associated with infections from different clinical sites. Most literature reports that P. mirabilis is the most common Proteus sp. isolated from clinical specimens (Feglo et al., 2010; Pal et al., 2014) . In this study, the most isolated species was P. mirabilis which accounted for 95.1% (194 out of 204) of samples.
Relating to the type of specimen associated with Proteus spp., urine is the highest type of specimen which accounted for 31.4%. This result is consistent with other studies done in Poland and Trinidad by Reslinski et al. (2005) and Orrett (1999) respectively who reported that Proteus species were more commonly encountered in urine than in other clinical specimens. On the other hand, studies by Newman et al. (2011) and Feglo et al. (2010) in Ghana and Yah et al. (2001) in Nigeria have described that Proteus spp. isolates were mostly recovered from wound swabs. Our results have also demonstrated Proteus spp. isolates were most frequently isolated from UTI. However there are limited past studies which documented the type of infection associated with Proteus spp.
The antimicrobial susceptibility patterns of Proteus isolates in this study were mostly represented by P. mirabilis. Proteus isolates are intrinsically resistant to polymyxin B and nitrofurantoin as shown in this study. All of the Proteus isolates were generally susceptible to the cephalosporin group (70.1-92.6%), beta lactam-beta lactamase inhibitor (72.1-99.0%), ciprofloxacin (69.6%) and aminoglycosides (76.8-96.9%). These findings were comparable with the study done by Bahashwan et al. (2013) except that his study had reported high levels of ciprofloxacin resistance among P. mirabilis isolates. On the other hand, more than 50% of the isolates recovered were resistant to ampicillin and trimethoprimsulfamethoxazole while nearly half of the non-urine isolates were resistant to chloramphenicol. Feglo et al. (2010) had also found similar results for the respective antibiotics.
In the present study, all 204 isolates were susceptible towards ertapenem and meropenem while 5.5% showed reduced susceptibility to imipenem by disc diffusion. This finding is much lower compared to previous studies which gave rates of reduced susceptibility to imipenem between 7 to 32.8% (Mutnick et al., 2002; Bahashwan et al., 2013; Pal et al., 2014; Wang et al., 2014) . The mechanism of resistance might result from altered PBPs (Neuwirth et al., 1995) or due to imipenem selective pressure by means of modulated efflux pump and porin genes (Pavez et al., 2016) . Therefore, the susceptibility of P. mirabilis to carbapenems should be determined by ertapenem, meropenem, or doripenem (Wang et al., 2014) by either disk diffusion or MIC method (CLSI, 2015) .
We also did a comparison between the imipenem zone diameter and individual E-test value which showed that 12 Proteus isolates were either intermediately susceptible or resistant by imipenem disc diffusion while only 2 isolates had reduced susceptibility when tested using E-test. Our findings showed that the zone diameter does not truly reflect the MIC value and thus, in isolates which are tested to have reduced susceptibility or resistant to imipenem should always be followed by MIC testing (CDC, 2010) . The E-test is easy to execute as the application is the same as the diffusion agar method. In comparison to broth dilution, E-test provides quantitative wide-range MICs, simple and the results are reproducible.
CONCLUSION
In conclusion, the prevalence of Proteus species with reduced susceptibility to imipenem is still low (1%). However, all isolates had shown susceptibility towards tazobactam-piperacillin, ertapenem and meropenem hence are potential antibiotics for empirical therapy. Proteus spp. was isolated mostly from urine, pus and tissue. Urinary tract infection was the type of infection that commonly associated with Proteus spp.
